A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated

NCT05183360 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

48

Enrollment

INDUSTRY

Sponsor class

Stopped Company decision

Conditions

Healthy

Interventions

DRUG: BI 706321
DRUG: Placebo

Sponsor

Boehringer Ingelheim